Nature Medicine
Semaglutide may protect kidneys by reducing vascular resistance
In a 52-week trial of 106 people with type 2 diabetes and chronic kidney disease, semaglutide reduced renal vascular resistance without altering coprimary imaging…In a 52-week trial of 106 people with type 2 diabetes and chronic kidney disease, semaglutide reduced renal vascular resistance without altering coprimary imaging endpoints.
Randomised trial in 106 peopleSemaglutide